Cancer Biology Cancer Treatment Medical Research Cancer Research Cancer Cancer Research Cancer Research Patient Outcomes Clinical Research Colon Cancer
A NYU Langone Health study uncovered a reliance on EGFR signaling in NF1-mutant tumors prompting early-phase trials of cetuximab plus afatinib.